Medtech Insight

Inivata Launches Major US Study To Back Liquid Biopsy Tech In Lung Cancer

12 Oct 2016

• By Catherine Longworth

Cambridge University spin-out Inivata has launched a major US clinical validation study to evaluate its liquid biopsy approach against tissue-based diagnostic methods in non-small cell lung cancer patients.

MT1610_LabUS_1200x675 — Inivata launch major US study to back liquid biopsy tech in lung cancer • Source: Inivata

Cancer genomics company Inivata Ltd.is embarking on a large-scale clinical validation study (INI-001) for circulating tumour DNA (ctDNA) analysis in non-small cell lung cancer.

INI-001 will be conducted at more than 30 centers in the US and is expected to recruit several hundred patients....